Home
Quality Matters

Main navigation

  • Global Health
  • Medicines
  • Dietary Supplements & Food

Mobile Menu

  • Global Health
  • Medicines
  • Dietary Supplements & Food
  • Contributors
  • Videos
  • USP.org
  • Contact us

Follow Us

  • LinkedIn
  • Twitter
  • Facebook
  • Youtube
Muhammad Hamid Zaman, Ph.D. Biography Photo

Muhammad Hamid Zaman, Ph.D.

Howard Hughes Medical Institute Professor of Biomedical Engineering, Boston University
Twitter Twitter

Muhammad Hamid Zaman, PhD, is the Howard Hughes Medical Institute Professor of Biomedical Engineering and International Health at Boston University. Dr. Zaman’s current research is focused on developing robust technologies, and systems-level solutions, to improve the quality of medicines, particularly as they are related to mortality and morbidity issues associated with antimicrobial resistance. Technologies developed by Dr. Zaman and his lab are in various stages of implementation in a number of developing countries. Scientific American has named technologies from the Zaman lab among the top 10 technologies that will change the world. Dr. Zaman is also part of the advisory committee to implement the United Nations Sustainable Development Goals (SDG) in his native Pakistan where he is working with both public and the private sector. Dr. Zaman holds a Ph.D. in Chemistry from the University of Chicago.

Dr. Zaman currently works on projects in multiple countries including Pakistan, Ghana, Tanzania, Zambia, Indonesia, Lebanon and Brazil. Dr. Zaman also works with frontline public health and refugee relief organizations in Syria and Lebanon, developing engineering solutions to address medical needs in a sustainable manner. His latest book, Bitter Pills (Oxford University Press, 2018), looks at the global challenge of substandard and falsified drugs and the need for integrated solutions, ranging from innovation and technology to public health and regulation, to address the global crisis in the prevalence of substandard drugs and how they relate to global antimicrobial resistance challenges.

Medicines
 // June 16, 2020

Dangerous convergence: COVID-19, substandard antibiotics and AMR

Antimicrobial resistance (AMR) is a global health challenge which can undermine standard treatmen

Carly Ching, Ph.D. Biography Photo
Muhammad Hamid Zaman, Ph.D. Biography Photo
Carly Ching, Ph.D. Muhammad Hamid Zaman, Ph.D.
Dangerous convergence: COVID-19, substandard antibiotics and AMR

Get the latest from Quality Matters to your inbox

Follow Us

  • LinkedIn
  • Twitter
  • Facebook
  • Youtube

Footer

  • Contributors
  • Videos
  • USP.org
  • Contact

Footer Copyright

  • Commenting Policy
  • Privacy Policy
  • Terms of Use

© The United States Pharmacopeial Convention